#Peru #Boca Raton #AMR #Arkstone #Neslab

Arkstone and Neslab Team Up to Revolutionize Healthcare in Peru

In a landmark partnership, Arkstone Medical Solutions has joined forces with Neslab, a premier medical technology company from Peru. The objective of this collaboration is to significantly enhance the treatment landscape for infectious diseases throughout the country. By leveraging cutting-edge technology, this initiative aims to improve the accessibility and effectiveness of healthcare for millions of Peruvians.

Addressing the Antimicrobial Resistance Challenge

Antimicrobial resistance (AMR) is a growing concern globally, affecting healthcare standards and patient outcomes. Arkstone is stepping up to tackle this pressing issue by deploying its state-of-the-art antimicrobial stewardship tools alongside Neslab's expertise and existing software capabilities. This coalition will introduce innovative data-driven clinical insights to physicians, enabling proactive and precision-driven care for infectious diseases.

Steve Brennan, the Global Partnerships Manager at Arkstone, commented on the significance of this partnership, stating, "Most healthcare systems outside the US are mainly government-managed, and our alliance with Neslab allows us to reach a broader patient population beyond just private labs and clinics." This reach is crucial as it aligns with Arkstone's mission to combat AMR and to ensure that reliable treatment options are available across diverse healthcare settings.

AI-Enhanced Clinical Decision Support

A standout feature of this partnership is the integration of Arkstone's OneChoice technology. This AI-enhanced clinical decision support system provides optimized treatment recommendations that are vital for healthcare professionals in Peru. When combined with Neslab's SIMCORE software, doctors will gain access to real-time guidance that is both evidence-based and locally relevant, thus facilitating a more efficient approach to antibiotic stewardship.

With this new setup, healthcare providers will be able to quickly identify when antibiotics should be used and when they can be withheld, effectively reducing inappropriate and unnecessary use. This means better care for patients and a strategic move towards bridging the existing gaps in public health infrastructure.

Local Support with Global Standards

Martin Cuba, General Manager of Neslab, expressed enthusiasm about the alliance, indicating that it represents a significant milestone in Peruvian healthcare. Cuba noted, "This collaboration underscores our commitment to providing scalable solutions in the fight against antimicrobial resistance and bridging the gap in antimicrobial stewardship.”

The partnership is not just focused on advanced technology, but also integrates local insights and practices, ensuring that solutions are adaptable to the unique challenges faced by Peruvian healthcare providers.

A Future-Focused Approach

Ari Frenkel, Chief Science Officer at Arkstone, emphasized that this initiative is about creating sustainable and scalable healthcare solutions. He remarked, "This partnership exemplifies our dedication to improving healthcare delivery by making cutting-edge tools accessible to clinicians on the ground level. Together, we are setting a precedent for the future of infectious disease management in Peru."

The collaboration aims to create a seamless connection between healthcare providers and the latest advancements in treatment, ensuring that every patient receives accurate and timely care. With a focus on harnessing technology, the alliance between Arkstone and Neslab is poised to effect real change in patient health outcomes across the region.

For those interested in learning more about this transformative partnership, comprehensive details can be found on Neslab’s official website and Arkstone's site.